About US
Contact us
-
Novartis signs Chinese manufacturing deal with Cellular Biomedicines for KymriahSwiss pharmaceutical company Novartis has signed an exclusive marketing agreement with Cellular Biomedicines to manufacture its CAR-T therapy Kymriah in China. The agreement is part of Novartis’ effo2018/9/29
-
US and Cuba form biotech joint venture to develop cancer drugsUS and Cuba have formed a biotech joint venture, called Innovative Immunotherapy Alliance, focused on the research and development of cancer drugs to prolong and improve survival of patients2018/9/29
-
Big Pharma's antibody drugs for asthma show benefits but cost 50% too much: ICERNew antibody-based treatments are better than traditional drugs for moderate to severe asthma, but they still cost too much, a U.S. drug cost watchdog says. More than 50% too much, in fact. In a newd2018/9/28
-
How Samsung BioLogics’ end-to-end service maximizes client satisfactionSamsung BioLogics has come a long way in seven years. Having started out as a CMO, the company has grown into an end-to-end service provider with capabilities spanning far beyond manufacturing, enabli2018/9/28
-
AstraZeneca sharpens Imfinzi's lung cancer edge with big survival winAstraZeneca already has an OK to market Imfinzi for stage 3 lung cancer that can't be surgically removed. But just-unveiled survival data will strengthen its case—and its lead over its immuno-oncology2018/9/27
-
EMA feeling better about drug supply interruptions from BrexitThe European Medicines Agency says concerns over drug shortages stemming from Brexit have eased, but not all drugmakers feel the same. The EMAreportedthis week that it has revised its list of drugs w2018/9/27
-
Takeda and Molecular Templates partner on protein-based cancer therapyTakeda Pharmaceutical has signed a licence, development and commercialisation agreement with drug development firm Molecular Templates to co-develop protein-based treatments for cancer. The partners2018/9/26
-
Pharma Technology Focus – Issue 75Pharma Technology Focus is now available on all devices.Read it for freehere. Researchers from the University of Toronto have published an overview of clinical trial and health data transparency acro2018/9/26
-
NHS wins landmark ruling against pharma companies over AMD drugThe UK High Court has ruled in favour of the NHS regarding the use of a cheaper, unlicensed drug for common eye condition wet age-related macular degeneration (AMD) over the much more expensive treatm2018/9/25
-
Amicus Therapeutics to buy Celenex for $100m upfrontUS-based biotechnology firm Amicus Therapeutics has entered into a definitive agreement to buy clinical stage gene therapy firm Celenex for $100m in an upfront payment. The transaction will fetch Ami2018/9/25